Compare Bumble Inc (BMBL) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bumble Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Bumble Inc trades at $2.82 (market cap $366.87M), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 223.7× Bumble Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Bumble Inc pays none. Which is the better fit depends on your goals.
| BMBL | REGN | |
|---|---|---|
Market Cap | $366.87M | $82.06B |
Sector | Technology | Health |
52-Week High | $7.17 | $812.27 |
52-Week Low | $2.70 | $555.51 |
Enterprise Value | $672.73M | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bumble Inc
Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come on a monthly basis to discover new people and connect with each other.
Read more on BMBL →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
